In addition to being the primary contributor on MunAiMarkets, Lorimer also is a prolific contributor to TalkMarkets.com with additional weekly articles on all things AI, cannabis, psychedelic, gold/silver stocks-related and all aspects of the computer chips related/semiconductor sector. If you want even more original – and timely – analyses of stocks on those areas please go here.
Latest Posts
- Our Conservative Cannabis Stock Portfolio Continues To Outperform – Monday, Sept. 16
- “Our Conservative Cannabis Stocks Portfolio has outperformed our Canadian Cannabis LP Stocks Portfolio by more than a 3 to 1 margin on an annual basis.”
- Views:
- Pure-Play Cybersecurity Software Stocks Bounced Back Last Week – Monday, Sept. 16
- “Research forecasts corporate spending on cybersecurity growing at a CAGR of 13.8% between now and 2030 suggesting that many cybersecurity software companies should be excellent long-term buys. This article highlights 4 such pure-play companies.”
- Views: 663
- Our AI Mega-Cap Portfolio +6 Last Week Vs. -5% The Previous Week – Monday, Sept. 16
- The 6 mega-cap stocks were down 5% w/e Sept. 6th after the ISM manufacturing index reported August figures below consensus raising fears about the health of the economy. That fear subsided during the w/e Sept. 13 with all 6 stocks moving up.
- Views: 923
- Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week – Sunday, Sept. 15
- “The psychedelic compound-based drug market is expected to triple over the next few years, creating many winning stocks in the years to come.”
- Views: 930
- AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week – Sunday, Sept. 15
- “The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual sales in excess of $50B.”
- Views: 981
- Cannabis LP Stocks Were +6% Last Week Vs. -10% The Previous Week – Sunday, September 15
- “The Canadian Cannabis LP Stocks Portfolio was up +6% last week from a 10% decline w/e Sept. 6th as the negative sentiment waned surrounding the DEA’s announcement that it would be having a December 2nd hearing to consider additional opinions.”
- Views: 677